Importance The evidence for benefit of convalescent plasma for critically ill patients with
COVID-19 is inconclusive. Objective To determine whether convalescent plasma would improve …

Treatment of severe COVID-19 is currently limited by clinical heterogeneity and incomplete
description of specific immune biomarkers. We present here a comprehensive multi-omic …

Background Direct evaluation of vascular inflammation in patients with COVID-19 would
facilitate more efficient trials of new treatments and identify patients at risk of long-term …

Background Anaemia is common and associated with poor outcomes in survivors of critical
illness. However, the optimal treatment strategy is unclear. Methods We conducted a …

Critical illness in COVID-19 is an extreme and clinically homogeneous disease phenotype
that we have previously shown 1 to be highly efficient for discovery of genetic associations 2 . …

Critical COVID-19 is caused by immune-mediated inflammatory lung injury. Host genetic
variation influences the development of illness requiring critical care 1 or hospitalization 2 , 3 – …

ABSTRACT Treatment of severe COVID-19 is currently limited by clinical heterogeneity and
incomplete understanding of potentially druggable immune mediators of disease. To …

The overarching aims of the work to be presented in this thesis are to investigate the role of
intravenous iron for treating anaemia in survivors of critical illness and to improve our …

Plant pests, pathogens, and their causal diseases account for more than 40% evidential
crop loss. They naturally impede the overall growth and yield of cultivated and stored crops. …

Introduction: Various types of COVID-19 vaccines are being used globally to control the
current pandemic. Post-licensure surveillance of vaccines is essential to ensure safety. This …